These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 8869177)
1. The United Kingdom cystic fibrosis epidemiology study. Smyth RL; Ashby D Postgrad Med J; 1996 Mar; 72 Suppl 2():S4-10; discussion S7-10. PubMed ID: 8869177 [No Abstract] [Full Text] [Related]
2. Update on the United States epidemiology study. Littlewood JM Postgrad Med J; 1996 Mar; 72 Suppl 2():S6; discussion S7-10. PubMed ID: 8869178 [No Abstract] [Full Text] [Related]
3. The aetiology of fibrosing colonopathy. Dodge JA Postgrad Med J; 1996 Mar; 72 Suppl 2():S52-5. PubMed ID: 8869183 [No Abstract] [Full Text] [Related]
4. Fibrosing colonopathy in children with cystic fibrosis. Postgrad Med J; 1996 Mar; 72 Suppl 2():S11-29. PubMed ID: 8869179 [No Abstract] [Full Text] [Related]
6. Case report: colonic stricture and fibrosis associated with high-strength pancreatic enzymes in a child with cystic fibrosis. McHugh K; Thomson A; Tam P Br J Radiol; 1994 Sep; 67(801):900-1. PubMed ID: 7953234 [TBL] [Abstract][Full Text] [Related]
7. Colonic stricture in a boy with cystic fibrosis. Ong PS; Oades PJ; Bush A; Brereton RJ Postgrad Med J; 1995 May; 71(835):309-12. PubMed ID: 7596943 [TBL] [Abstract][Full Text] [Related]
8. Comparative and experimental pathology of fibrosing colonopathy. van Velzen D; Ball LM; Dezfulian AR; Southgate A; Howard CV Postgrad Med J; 1996 Mar; 72 Suppl 2():S39-48; discussion S49-51. PubMed ID: 8869182 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of enteric-coated preparations on nutritional parameters in cystic fibrosis. A long-term study. Carroccio A; Pardo F; Montalto G; Japichino L; Iacono G; Collura M; Notarbartolo A Digestion; 1988; 41(4):201-6. PubMed ID: 3243379 [TBL] [Abstract][Full Text] [Related]
10. Colonic wall thickness, pancreatic enzyme dose and type of preparation in cystic fibrosis. Ramsden WH; Moya EF; Littlewood JM Arch Dis Child; 1998 Oct; 79(4):339-43. PubMed ID: 9875045 [TBL] [Abstract][Full Text] [Related]
11. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis]. Zsíros J; Sólyom E Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773 [No Abstract] [Full Text] [Related]
12. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Smyth RL; Ashby D; O'Hea U; Burrows E; Lewis P; van Velzen D; Dodge JA Lancet; 1995 Nov; 346(8985):1247-51. PubMed ID: 7475715 [TBL] [Abstract][Full Text] [Related]
13. Colonic wall thickening is related to age and not dose of high strength pancreatin microspheres in children with cystic fibrosis. Connett GJ; Lucas JS; Atchley JT; Fairhurst JJ; Rolles CJ Eur J Gastroenterol Hepatol; 1999 Feb; 11(2):181-3. PubMed ID: 10102230 [TBL] [Abstract][Full Text] [Related]
14. Treatment of steatorrhoea in cystic fibrosis: a comparison of enteric-coated microspheres of pancreatin versus non-enteric-coated pancreatin and adjuvant cimetidine. Stead RJ; Skypala I; Hodson ME Aliment Pharmacol Ther; 1988 Dec; 2(6):471-82. PubMed ID: 2979269 [TBL] [Abstract][Full Text] [Related]
15. Hypoalbuminemia at diagnosis as a marker for severe respiratory course in infants with cystic fibrosis identified by newborn screening. Abman SH; Reardon MC; Accurso FJ; Hammond KB; Sokol RJ J Pediatr; 1985 Dec; 107(6):933-5. PubMed ID: 3851839 [No Abstract] [Full Text] [Related]
16. Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis. Croft NM; Marshall TG; Ferguson A Postgrad Med J; 1996 Mar; 72 Suppl 2():S32-6. PubMed ID: 8869180 [TBL] [Abstract][Full Text] [Related]
18. Porcine pancreatin as a source of salmonella infection in children with cystic fibrosis. Lipson A; Meikle H Arch Dis Child; 1977 Jul; 52(7):569-72. PubMed ID: 879849 [TBL] [Abstract][Full Text] [Related]